Source: http://www.brainhealtheducation.org/is-there-a-place-for-cbd-in-the-treatment-of-psychiatric-disorders/
CBD has a complex mode of action which includes inverse agonism (functionally an antagonist) of CB1 and CB2 cannabinoid receptors, mild monoamine uptake inhibition, and 5-HT1A agonism. Additionally, reviews based on preclinical and clinical research identify CBD as an anxiolytic, antipsychotic, anti-insomnia and antidepressant agent. Furthermore, it has putative anti-inflammatory, antidiabetic, analgesic, and neuroprotective properties. Adjunct
Read More…
…
Source: http://www.brainhealtheducation.org/is-there-a-place-for-cbd-in-the-treatment-of-psychiatric-disorders/
CBD has a complex mode of action which includes inverse agonism (functionally an antagonist) of CB1 and CB2 cannabinoid receptors, mild monoamine uptake inhibition, and 5-HT1A agonism. Additionally, reviews based on preclinical and clinical research identify CBD as an anxiolytic, antipsychotic, anti-insomnia and antidepressant agent. Furthermore, it has putative anti-inflammatory, antidiabetic, analgesic, and neuroprotective properties. Adjunct
Read More…
…
What Do You Think?
comments